secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOLASE, INC (—)
CIK:        0000811240
Form:       8-K
Filed at:   2024-02-15T23:59:59+00:00
Accession:  0001193125-24-037654
Event type: other_material
Sentiment:  negative
Materiality: 0.75
Item codes: 1.01, 3.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BIOLASE closes $7M public offering; Nasdaq extends compliance deadline to March 31, 2024
--------------------------------------------------------------------------------

- Raised ~$7.0M gross in public offering of 16M units at $0.44/unit with Class A and Class B warrants.
- Class A warrants exercisable at $0.66/share for 5 years; Class B warrants at $0.748 upon stockholder approval.
- Issued investor warrant for 2,221,880 shares; December 2023 warrants repriced to $0.2256 per share.
- Nasdaq granted extension to meet minimum equity rule until March 31, 2024, conditioned on offering closing.
- Post-offering shares outstanding: 19,195,024 (including 7.2M from pre-funded warrant exercises).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/811240/000119312524037654/0001193125-24-037654-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/811240/000119312524037654/d780376d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-037654

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer